REFERENCES
- Atkinson J, Niepel B, Jüppner H, Butz R, Casaretto M, Zahn H, Hehrmann R, Hesch RD. Homologous radioimmunoassay for human mid-regional parathyroid hormone. J Endocrinol Invest 1981; 4: 363–366.
- Berson SA, Yalow RS. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 1968; 28: 1037–1047.
- Delmas PD, Wilson DM, Mann KG, Riggs BL. Effect of renal function on plasma levels of bone gla-protein. J Clin Endocrinol Metab 1983; 57: 1028–1030.
- Epstein S, Traberg H, Raja R, Poser J. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab 1985; 60: 1253–1256.
- Fuchs C, Doht B, Dorn D, McIntosh C, Ritter D, Scheler F. Parathyroid hormone, calcium and phosphate balance in hemofiltration. J Dial 1977; 1: 631–640.
- Gundberg CM, Hanning RM, Liu YA, Zlotkin SH, Balfe JW, Cole DEC. Clearance of osteocalcin by peritoneal dialysis in children with end-stage renal disease. Pediatr Res 1987; 21: 296–300.
- Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. Determination of osteocalcin in human serum: Results with two kits compared with those by a well-characterized assay. Clin Chem 1985; 31: 1720–1723.
- Habener JF, Rosenblatt MJr, Potts JTJr. Parathyroid hormone. Biochemical aspects of biosynthesis, secretion, action and metabolism. Physiol Rev 1984; 64: 985–1083.
- Jüppner H, Atkinson M, Ringe B, Krohn HP, Hesch RD. Mitt-C-regionales Parathormon in der klinischen Routine: Diagnostische Wertigkeit beim extrarenalen (primären) und renalen (sekundären) Hyperparathyreoidismus. Klin Wchschr 1986; 64: 281–286.
- Jörstad S, Smeby LC, Balstad T, Wideröe T-E. Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. Blood Purif 1988; 6: 96–105.
- Lilienfeld-Toal von H, Gerlach I, Klehr HU, Issa S, Keck E. Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron 1982; 31: 116–122.
- Malluche HH, Faugere MC, Fanti P, Price PA. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984; 26: 869–874.
- Massry SG. Current status of the role of parathyroid hormone in uremic toxicity. Contr Nephrol 1985; 49: 1–11.
- Nilsson P, Weiss L, Melsen F, Danielson BG, Wide L. Chronic hemofiltration: effects on calcium homeostasis, parathyroid function and bone histomorphometry. Scand J Urol Nephrol 1984; Suppl 84: 47–50.
- Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism: Measurement by radioimmunoassay of bone Gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66: 878–883.
- Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981; 256: 12760–12766.
- Rittinghaus EF, Jüppner H, Burdelski M, Hesch RD. Selective determination of C-terminal (70–84) hPTH: elevated concentrations in cholestatic liver disease. Acta Endocrinol 1986; 111: 62–68.
- Schaefer K, Herrath von D, Gullberg CA, Asmus G, Hüfler M, Offermann G, Cremer H, Heuck CC, Ritz E. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood. Artif Organs 1978; 2: 386–394.
- Sebert JL, Fournier A, Leflon P, Fohrer P, Frémont de JF, Morinière P, Galy C, Marie A, Demontis R, Boudailliez B, Gueris J, Dkhissi H, Garabedian M, Lambrey G. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration. Nephron 1986; 42: 34–40.
- Streicher E, Schneider H, Knödler U, Müller H, Spohr U, Schmidt-Gayk H. Chronic hemofiltration treatment. Artif Organs 1980; 4: 48–57.
- Weiss L, Danielson BG, Wikström B. Four years' experience of long-term hemofiltration in a Swedish center. Scand J Urol Nephrol 1989; 23: 223–229.